Metabolomics Workbench : NIH Data Repository

(Analysis AN002435)

Metabolite	Structure	F1	F2	F3
Gln-3_2	ME342704	NA	0.41	1.59
Glu-4_2	ME342717	NA	0.47	1.53
GSH+GSSG-4_5	ME342702	NA	0.47	1.53
Nicotin-2_1	ME342731	0.84	1.87	0.73
Gln-4_1	ME342705	1.23	1.41	0.63
NAD+-N1^_2	ME342730	1.27	1.78	0.46
GSH+GSSG-3_1	ME342697	2.39	0.14	0.82
NAD+-A1^_2	ME342728	2.15	0.52	0.33
Glu-3-a_2	ME342710	1.94	0.59	0.37
UXP-1^_1	ME342735	1.87	0.45	0.40
Glu-3-a_3	ME342711	0.68	1.06	1.29
AXP-8_1	ME342688	0.97	0.37	1.42
GSH+GSSG-4_3	ME342700	0.78	0.40	1.38
Glycogen_1	ME342720	1.14	0.28	1.22
Gln-4_2	ME342706	1.02	0.41	1.12
bGlc_2	ME342738	1.18	0.48	1.09
Succinate-2,3_1	ME342734	1.07	0.60	1.15
Lac-2_3	ME342724	0.36	NA	1.32
Glu-3-a_4	ME342712	0.75	NA	1.13
pyruvate-3_1	ME342740	0.78	NA	1.11
m-Ins-2?_1	ME342739	1.29	NA	0.71
GSH+GSSG-4_2	ME342699	0.99	0.92	1.05
aGlc_1	ME342736	1.00	1.08	0.97
bGlc_1	ME342737	1.09	1.01	0.90
DSS_1	ME342696	1.04	1.02	0.95
CXP-6_1	ME342694	1.18	1.01	0.82
Lac-2_1	ME342722	1.28	1.03	0.70
Gly_1	ME342719	1.16	0.80	0.94
Asp-3b_2	ME342693	1.23	0.85	0.82
Glu-3-b_1	ME342714	1.20	0.83	0.89
P-Cho A_1	ME342733	1.18	0.86	0.86
Ala-3_1	ME342690	1.28	0.64	0.90
NAD+-A1^_1	ME342727	1.33	0.72	0.87
AXP-2_1	ME342687	1.29	0.78	0.82
Lac-3_1	ME342725	1.27	0.79	0.83
GSH+GSSG-4_4	ME342701	1.62	0.79	0.64
Ala-3_2	ME342691	1.31	0.53	0.84
Glu-4_1	ME342716	1.40	0.54	0.82
Nicotin-6_1	ME342732	1.46	0.64	0.82
Lac-2_2	ME342723	1.36	0.64	0.82
Lac-3_2	ME342726	1.36	0.65	0.82
AXP-1^_1	ME342685	1.48	0.49	0.77
NAD+-N1^_1	ME342729	1.52	0.58	0.68
GSH+GSSG-4_1	ME342698	1.67	0.39	0.64
Gln-3_1	ME342703	1.55	0.37	0.76
Glu-3-a_1	ME342709	1.58	0.31	0.77
Asp-3b_1	ME342692	1.43	0.33	0.90
Gln-4_3	ME342707	1.33	0.21	0.79

F1	Treatment Protocol:allogenic
F2	Treatment Protocol:naive
F3	Treatment Protocol:syngenic

Data matrix